1-10 of 10
Oral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
CME/CEOral GLP-1 RA Therapy in Type 2 Diabetes and High Cardiovascular Risk
Brian P. McDonough, MD, FAAFP
Silvio Inzucchi, MD
Jay H. Shubrook, DO, FACOFP, FAAFP
Patient Portal: Leveraging Technology to Improve Safety with Clinical Decision-Making for People with Diabetes
CME/CEPatient Portal: Leveraging Technology to Improve Safety with Clinical Decision-Making for People with Diabetes
Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
Eden Miller, DO, D-ACD, D-ABOM
A New Lens on DKA: Leveraging the Latest Tech for Improved Patient Outcomes
CME/CEA New Lens on DKA: Leveraging the Latest Tech for Improved Patient Outcomes
Jennifer Goldman, PharmD, CDCES, BC-ADM-FCCP
Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
Diabetes Educators EmpowerED: Strategies for Optimizing Patient Outcomes With Emerging Weekly Insulin Therapies
CME/CEDiabetes Educators EmpowerED: Strategies for Optimizing Patient Outcomes With Emerging Weekly Insulin Therapies
Mara Fiorio, DCN, RD, LD, BC-ADM, CDCES
Diana Isaacs, PharmD, BCACP, BC-ADM, CDCES, FADCES, FCCP
Richard E. Pratley, MD
DKA in the Real World: Evidence and Cases that Matter
CME/CEDKA in the Real World: Evidence and Cases that Matter
Carol Wysham, MD
Samuel Seidu, MD, FRCP(Edin), FRCGP
Leveraging CGM to Its Full Potential in People with T2D
CME/CELeveraging CGM to Its Full Potential in People with T2D
John E. Anderson, MD
Davida F. Kruger, CNP
- advertisement
Shifting Gears in Cardio-Renal-Metabolic Care: Harnessing Evidence-Based Therapies to Optimize Patient Outcomes
CME/CEShifting Gears in Cardio-Renal-Metabolic Care: Harnessing Evidence-Based Therapies to Optimize Patient Outcomes
Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Stephen J. Greene, MD
Anne Louise Peters, MD
DKA in Focus: What the New Consensus Means for Practice
CME/CEDKA in Focus: What the New Consensus Means for Practice
Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
Jennifer Sherr, MD, PhD
Optimize Outcomes in CKD & T2D: A Practical Approach to Initiating and Monitoring Combination ns-MRA & SGLT2i Therapy
CME/CEOptimize Outcomes in CKD & T2D: A Practical Approach to Initiating and Monitoring Combination ns-MRA & SGLT2i Therapy
Amy Mottl, MD, MPH
Prof. Christoph Wanner
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
CME/CERevolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
Scott Kahan, MD, MPH
Ken Fujioka, MD
Carol Wysham, MD
- advertisement
